• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-21A
Device Problems Backflow (1064); Obstruction of Flow (2423); Material Split, Cut or Torn (4008)
Patient Problems Aortic Valve Stenosis (1717); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Type  Injury  
Manufacturer Narrative
The results, method, and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
It was reported on (b)(6) 2021, that a 21 mm trifecta¿ gt valve was implanted in a patient with the comorbidities of obesity, dyslipidemia, and a past thyroidectomy.On an unknown date, the patient presented with acute aortic insufficiency due to grade 4 valvular regurgitation from valve deterioration.On (b)(6) 2021, the valve was explanted and replaced with a 19 mm non-abbott device to resolve the event.Upon explant, it was noted that there was a large tear from one stent post to another.The patient is recovering.No additional information was provided.
 
Manufacturer Narrative
The results, method, and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
It was reported on (b)(6) 2021, that a 21 mm trifecta¿ gt valve was implanted in a patient with the comorbidities of obesity, dyslipidemia, and a past thyroidectomy.On an unknown date, the patient presented with acute aortic insufficiency due to grade 4 valvular regurgitation from valve deterioration.On (b)(6) 2021, the valve was explanted and replaced with a 19 mm non-abbott device to resolve the event.Upon explant, it was noted that there was a large tear from one stent post to another.The patient is recovering.No additional information was provided.
 
Manufacturer Narrative
Additional information: a2.Correction: b5, d6a, h6.
 
Event Description
It was reported that on (b)(6) 2018, a 21 mm trifecta¿ gt valve was successfully implanted in a patient with severe aortic stenosis.The patients comorbidities are obesity, dyslipidemia, and a past thyroidectomy.On an unknown date, the patient presented with cardiac decompensation, moderate stenosis, and acute aortic insufficiency due to grade 4 valvular regurgitation from valve deterioration.On (b)(6) 2021, the valve was explanted and replaced with a 19 mm non-abbott device to resolve the event.Upon explant, it was noted that there was a large tear from one stent post to another.The patient is recovering.No additional information was provided.
 
Manufacturer Narrative
An event of cardiac decompensation, stenosis, aortic insufficiency, valvular regurgitation, "a large tear from one stent post to another", and device explant was reported.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿ GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
Manufacturer (Section G)
ST. JUDE MEDICAL, COSTA RICA LTDA
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS   01897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key13120171
MDR Text Key285194713
Report Number3014918977-2021-00130
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018212
UDI-Public05415067018212
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/30/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/16/2019
Device Model NumberTFGT-21A
Device Catalogue NumberTFGT-21A
Device Lot Number5845270
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/16/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-